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Abstract
Several alphaherpesviruses breach the basement membrane during mucosal invasion. In the present study, the role
of proteases in this process was examined. The serine protease-specific inhibitor AEBSF inhibited penetration of the
basement membrane by the porcine alphaherpesvirus pseudorabies virus (PRV) by 88.1% without affecting lateral
spread. Inhibitors of aspartic-, cysteine-, and metalloproteases did not inhibit viral penetration of the basement
membrane. Further analysis using the Soybean Type I-S trypsin inhibitor for the serine protease subcategory of
trypsin-like serine proteases resulted in a 96.9% reduction in plaque depth underneath the basement membrane.
These data reveal a role of a trypsin-like serine protease in PRV penetration of the basement membrane.
Introduction, Methods and Results
The basement membrane (BM) constitutes part of the
extracellular matrix and creates a formidable barrier to
invading pathogens [1]. Crossing the BM may facilitate
viral access to blood vessels and nerves in the lamina
propria whereafter it may spread to internal organs. Fol-
lowing infection of respiratory epithelial cells, different
alphaherpesviruses are able to cross the BM facilitating
viral invasion in the body and leading to viremia, virus
dissemination and aggravated general clinical signs
[2-12]. Using porcine nasal respiratory mucosal explants,
we have previously confirmed that the porcine alphaher-
pesvirus pseudorabies virus (PRV) efficiently breaches
the BM [3]. The underlying mechanism of herpesvirus
passage across the BM is unknown.
Breach of the BM in disease states is best character-
ized in metastatic progression in oncology following
neoplastic establishment and often involves disruption
of the BM by proteolytic enzymes [13,14]. Therefore, in
the current study, we investigated whether proteases are
involved in alphaherpesvirus invasion through the BM.
We reported previously an in vitro model that enables
study and quantitative analysis of PRV invasion through
the BM in nasal respiratory mucosa [3,15]. Porcine nasal
respiratory explants were obtained as described pre-
viously [15]. Briefly, explants were stripped from the
surfaces of ventral turbinates and septum, and incubated
with the epithelial surface upwards on fine-meshed
gauze and cultured at the air-liquid interface with
serum-free medium (50% RPMI (Invitrogen, Paisley,
UK)/50% DMEM (Invitrogen) supplemented with 1 μg/
mL gentamycin (Invitrogen), 0.3 mg/mL glutamin
(VWR, West Chester, PA, USA), 0.1 mg/mL streptomy-
cin (Certa, Braine l’Alleud, Belgium) and 100 U/mL
penicillin (Continental Pharma, Puurs, Belgium)).
Explants were cultivated for 10 h before inoculation
with 600 μL medium containing 107 TCID50 of PRV
field strain 89V87 [16]. After incubation for 1 h,
explants were washed three times with serum-free
medium.
Proteases are classified according to their catalytic
activity: serine-, cysteine-, metallo- and aspartic pepti-
dases [17,18]. The effect of inhibition of these protease
types on PRV penetration through the BM was investi-
gated using Complete Mini Protease Inhibitor Cocktail
Tablets containing a proprietary mixture of several
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protease inhibitors with broad inhibitory specificity for
serine, cysteine, and metalloproteases (Roche Diagnos-
tics Corporation, Basel, Switzerland). To investigate the
involvement of aspartyl proteases, pepstatin A (Sigma,
St. Louis, MO, USA), was used. Inhibitor concentrations
were used as recommended by the manufacturer’s
instruction, one tablet complete Mini protease inhibitor
cocktail per 10 mL and 1 μg/mL pepstatin A. At 1 h
post inoculation (pi), medium was replaced by medium
with and without inhibitor for inhibitor-treated and
mock-treated explants respectively. Explants were
immersed for 1 h and then transferred again to the
gauze and cultivated with medium in the presence or
absence of inhibitor for inhibitor-treated and mock-trea-
ted explants respectively until sampling. Samples were
collected at 20 h pi, embedded in methocel® (Sigma)
and frozen at -70°C. The time point of sampling was
specified at 20 h pi because PRV was found to cross the
BM between 12 and 16 h pi (data not shown). Cryosec-
tions were made, fixed in methanol, stained for collagen
IV (BM component) and PRV and analyzed by confocal
microscopy. Viral invasion across and lateral spread
above the BM were analyzed using ImageJ, as reported
previously [3]. For each condition, maximal plaque lati-
tude and depth underneath the BM were measured for
10 plaques; triplicate independent experiments were
performed.
Figure 1 shows mean values + SD of duplicate inde-
pendent experiments for PRV invasion across and lateral
spread above the BM. Incubation of PRV-inoculated
explants with the serine-, cysteine- and metalloprotease
inhibitor cocktail resulted in a 94.9% reduction in dis-
tance covered underneath the BM. The plaque latitude
remained similar, indicating that the inhibitor did not
affect viral replication in general. Pepstatin A did not
reduce plaque depth underneath the BM. These results
suggest the involvement of a serine-, cysteine- and/or
metalloprotease in PRV invasion through the BM.
To further delineate which of the serine-, cysteine-
and/or metalloproteases are involved in PRV invasion
through the BM, type-specific inhibitors were used:
AEBSF (4-(2-Aminoethyl) benzenesulfonyl fluoride
hydrochloride) inhibits serine proteases, E-64 (trans-
Epoxysuccinyl-l-leucylamido-(4-guanidino)butane) inhi-
bits cysteine proteases and phosphoramidon inhibits
metalloproteases (Sigma). PRV-inoculated explants were
treated with 100 or 250 μM AEBSF, 1 or 10 μM E-64 or
10 μM phosphoramidon and the effect on the plaque
depth underneath the BM and the plaque latitude above
the BM was evaluated. Figure 2 shows a dose-dependent
decrease in the plaque depth underneath the BM when
using AEBSF at 100 and 250 μM where the inhibitor
reduced plaque depth underneath the BM by 58.7 and
88.1% respectively, compared with plaques from mock-
treated explants. E-64 and phosphoramidon did not
reduce plaque depth or latitude. These results suggest a
role for serine proteases in PRV invasion across the BM.
Based on their substrate specificity, serine proteases
are generally classified into three main categories: tryp-
sin-like, chymotrypsin-like and elastase-like serine pro-
teases [19]. The trypsin inhibitor from Glycine max,
Soybean Type I-S, was first isolated by Kunitz [20] and
inhibits trypsin-like serine proteases (Sigma). TPCK (N-
Figure 1 Plaque latitude and penetration depth underneath
the basement membrane (BM) of PRV(89V87) plaques at 20 h
pi in mock-treated (white bars) and protease inhibitor-treated
(marked bars) porcine nasal respiratory mucosa explants.
Explants were treated with a broad-spectrum protease inhibitor
cocktail (complete Mini), inhibiting serine, cysteine and
metalloproteases, or with an aspartyl protease inhibitor, pepstatin A,
at 1 h pi until sampling. Data are represented as means of 10
plaques of duplicate independent experiments + SD (error bars).
Figure 2 Plaque latitude and penetration depth underneath
the basement membrane (BM) of PRV(89V87) plaques at 20 h
pi in mock-treated (white bars) and protease inhibitor-treated
(marked bars) porcine nasal respiratory mucosa explants.
Explants were treated with 100 or 250 μM AEBSF, 1 or 10 μM E-64
or 10 μM phosphoramidon at 1 h pi until sampling. Data are
represented as means of 10 plaques of triplicate independent
experiments + SD (error bars).
Glorieux et al. Veterinary Research 2011, 42:58
http://www.veterinaryresearch.org/content/42/1/58
Page 2 of 5
p-Tosyl-L-phenylalanine chloromethyl keton) inhibits
chymotrypsin-like serine proteases and elastatinal is an
inhibitor of elastase-like serine proteases (Sigma) [21]. A
time course of protease inhibitor treatment was per-
formed for these three inhibitors. At different time
points pi, PRV-inoculated explants were either mock-
treated or treated with 5 mg/mL Soybean Type I-S, 100
μM TPCK or 100 μM elastatinal [21]. Treatment started
at 1 h pi, 3 h pi, 6 h pi, 9 h pi or 12 h pi until sampling
at 20 h pi. To this end, explants were immersed for 1 h
in medium with and without inhibitor at 1 h pi, 3 h pi,
6 h pi, 9 h pi or 12 h pi for inhibitor- and mock-treated
explants respectively. After 1 h immersion, explants
were transferred to the gauze and cultivated with med-
ium with and without inhibitor for inhibitor- and mock-
treated explants respectively until sampling. A wash-out
experiment with each of the inhibitors was also per-
formed. Therefore, inhibitor was added at 1 h pi,
explants were immersed for 1 h, washed three times,
transferred again to the gauze and cultivated with med-
ium without inhibitor. For each protease inhibitor/time
point combination, 120 cryosections (20 μm) were
made. Figure 3 gives the mean values of the plaque lati-
tude and depth underneath the BM of triplicate inde-
pendent time course experiments. Inhibition of trypsin-
like serine protease activity strongly reduced the plaque
depth underneath the BM with 96.9% (illustrated in Fig-
ure 4) when added at 1 h pi until sampling and with
45.4, 48.2, 10.0% when added starting from 3, 6 and 9 h
pi respectively until sampling. No reduction was
observed when the inhibitor was added starting from 12
h pi. Treating the inoculated explants with inhibitor at 1
h pi and washing out the inhibitor at 2 h pi resulted in
a 23.4% reduction in plaque depth underneath the BM
(data not shown). Plaque latitudes always remained
similar. No plaques were observed after treatment of
PRV-inoculated explants with TPCK, except for some
small plaques in two conditions of one of the 3 piglets.
As illustrated in Figure 3, elastatinal did not reduce the
plaque depth underneath the BM. The elastatinal wash-
out experiment also did not have an effect on either pla-
que latitude or depth underneath the BM (data not
shown).
Discussion
Interactions of herpesviruses with respiratory mucosa
remain poorly understood. Invasion of different alpha-
herpesviruses towards the lamina propria involves pas-
sage of the BM barrier. This facilitates viral access to
blood capillaries and nerve endings which enables
further dissemination throughout the body [2-12]. To
date, the mechanism of the alphaherpesvirus invasion
process through the BM barrier is unknown.
The current study shows that serine protease activity
is involved in PRV invasion through the BM. Over one
third of all known proteolytic enzymes are serine pro-
teases which mediate diverse biological processes requir-
ing timely and specifically regulated proteolytic activity,
where insufficient or excessive proteolysis can cause
pathological processes [22,23]. To date, knowledge of
the role of serine proteases in the pathology of herpes-
virus infections remains limited to the intracellular viral
replication cycle itself. Proteolytic cleavage of viral pro-
teins by cellular or viral proteases has been described in
different stages of the herpesvirus life cycle [24]. An
observation suggesting that proteases may modulate her-
pesvirus pathogenesis was made by Riteau et al. [25].
These authors suggest that herpesviruses can take
advantage of mediators of inflammatory processes,
namely extracellular proteases. Exposure of PRV-
infected cells to trypsin increases virus production
through activation of the extracellular signal-regulated
kinase (ERK)1/2 signaling pathway. Reports describing
protease-mediated extracellular matrix remodeling in
association with viral infection are limited. Human
papilloma virus (HPV) has been reported to induce both
matrix metalloproteinase 2 (MMP-2) and MMP-9, two
type IV collagenases. Type IV collagenases degrade the
collagen type IV component of the basement membrane
[26,27]. Two herpesviruses, Epstein-Barr virus (EBV)
and herpes simplex virus (HSV), have also been reported
to induce MMP-9 [14,28]. Whether this MMP-9 induc-
tion plays a role in EBV pathogenesis is unclear at pre-
sent [28]. HSV encephalitis is characterized by an early
MMP-9 increase and collagen type IV degradation
Figure 3 Plaque latitude (L) and penetration depth underneath
the basement membrane (D) of PRV(89V87) plaques at 20 h pi
in mock-treated (white bars) and protease inhibitor-treated
(marked bars) porcine nasal respiratory mucosa explants.
Explants were mock-treated or treated with a trypsin-like serine
protease inhibitor, Soybean Type I-S trypsin inhibitor, or with an
elastase-like serine protease inhibitor, elastatinal, at 1 h pi, 3 h pi, 6
h pi, 9 h pi or 12 h pi until sampling. Data are represented as
means of plaques observed in 120 sections (20 μm) of triplicate
independent experiments + SD (error bars).
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causing disruption of the neurovascular matrix. This
overexpression in proteolytic activity is believed to result
from central nervous system inflammation, rather than
from the viral infection itself and its role in pathogenesis
is unclear [14].
More specifically, in the current study, we demon-
strate that a trypsin-like serine protease is involved in
viral penetration of the BM. Since serine protease activ-
ity involvement has been described in different stages of
the herpesvirus life cycle [24], the effect of the Soybean
trypsin-like protease inhibitor on general PRV replica-
tion was tested in ST and MDCK cells. No defect in
viral replication was observed (data not shown), which
is consistent with the observation that none of the inhi-
bitors tested affected lateral viral spread above the BM
in explants (Figures 1, 2, 3 and 4). Inhibition of trypsin-
like serine protease activity strongly reduced the plaque
depth underneath the BM. The time course of trypsin-
like serine protease inhibitor treatment revealed less
prominent reductions in plaque depth underneath the
BM when explants were treated at later time points pi.
These results are in line with our observation that PRV
already crosses the BM between 12 and 16 h pi. In addi-
tion to trypsin-like proteases, serine proteases also
encompass chymotrypsin-like and elastase-like proteases
[29]. Therefore, a similar time course experiment was
performed using inhibitors for chymotrypsin-like
(TPCK) or elastase-like (elastatinal) serine proteases. No
plaques were observed after treatment with TPCK,
except for some small plaques in two conditions of one
of the 3 piglets (3 h pi and 6 h pi). This perhaps may
point to side or toxic effects of this inhibitor. Therefore,
the involvement of chymotrypsin-like serine protease
activity in PRV BM penetration could not be examined.
Elastatinal did not reduce the plaque depth underneath
the BM. However, since working solutions of elastase-
like serine protease inhibitors have a relatively low stabi-
lity (datasheet), we cannot formally exclude the possible
involvement of either chymotrypsin-like or elastase-like
serine protease activity in BM passage of PRV.
We can conclude that trypsin-like serine protease activ-
ity is involved in PRV invasion through the BM towards
the lamina propria. We hypothesize that this trypsin-like
serine protease activity is involved in local degradation of
Figure 4 Confocal photomicrographs illustrating PRV(89V87) plaques at 20 h pi in (a) mock-treated and (b) Soybean Type I-S trypsin
inhibitor-treated porcine nasal respiratory mucosa explants. Green fluorescence visualizes PRV antigens in virus plaques using FITC-
conjugated polyclonal PRV-specific antibodies. Collagen IV (component of basement membrane (BM), black dashed line) is visualized using goat
anti-collagen IV antibodies, stained afterwards with TexasRed. Figure (a) shows a representative image of two closely apposed viral plaques both
invading through the BM. Figure (b) illustrates the blocked viral invasion underneath the BM in the presence of a trypsin-like protease inhibitor.
Bar, 20 μm.
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BM barrier components, thereby enhancing BM penetra-
tion. An important question that remains is whether the
proteases involved are of cellular and/or viral origin. Inter-
estingly, transcriptome studies have indicated that several
cellular components involved in trypsin-like serine pro-
tease activity are differentially regulated upon infection
with alphaherpesviruses like PRV and HSV, including fac-
tor IX, tissue-type plasminogen activator (t-PA) and urin-
ary plasminogen activator receptor 1 (uPAR1) [30,31].
Further research will be aimed at identifying the proteases
involved and elucidating the exact molecular mechanism
of viral penetration through the BM.
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